Search research articles
Contact Us
Filters
Showing results (1-10 of 65) with videos related to
Page
of 7
Sort By:
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology
|
June 4, 2023
[Engineering memory-rich CAR-T cells by a piggyBac transposon system]
Shigeki Yagyu
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology
|
August 4, 2024
[Adoptive cell therapy for solid tumors]
Kenichi Sakamoto, Shigeki Yagyu
International Journal of Clinical Oncology
|
March 1, 2023
piggyBac-transposon-mediated CAR-T cells for the treatment of hematological and solid malignancies
Shigeki Yagyu, Yozo Nakazawa
BMJ Case Reports
|
January 1, 2022
Infantile mediastinal neuroblastoma presenting as an oncologic emergency: usefulness of serum-based <i>MYCN</i> gene amplification analysis for risk stratification
Masaya Suematsu, Shigeki Yagyu, Hajime Hosoi, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
May 30, 2015
An Inducible Caspase-9 Suicide Gene to Improve the Safety of Therapy Using Human Induced Pluripotent Stem Cells
Shigeki Yagyu, Valentina Hoyos, Francesca Del Bufalo, et al.
Molecular Therapy. Methods & Clinical Development
|
September 15, 2016
Multiple mechanisms determine the sensitivity of human-induced pluripotent stem cells to the inducible caspase-9 safety switch
Shigeki Yagyu, Valentina Hoyos, Francesca Del Bufalo, et al.
Biochemical and Biophysical Research Communications
|
October 24, 2022
Non-viral inducible caspase 9 mRNA delivery using lipid nanoparticles against breast cancer: An in vitro study
Ikumi Nakashima, Shoji Saito, Eiichi Akahoshi, et al.
Pediatric Blood & Cancer
|
March 4, 2011
Detection of MYCN DNA in the cerebrospinal fluid for diagnosing isolated central nervous system relapse in neuroblastoma
Tomiko Kimoto, Masami Inoue, Sadao Tokimasa, et al.
Cancer Cell International
|
June 4, 2020
Oncogenic role of HMGA2 in fusion-negative rhabdomyosarcoma cells
Kazutaka Ouchi, Mitsuru Miyachi, Shigeki Yagyu, et al.
Frontiers in Immunology
|
February 14, 2022
<i>PiggyBac</i> Transposon-Mediated CD19 Chimeric Antigen Receptor-T Cells Derived From CD45RA-Positive Peripheral Blood Mononuclear Cells Possess Potent and Sustained Antileukemic Function
Masaya Suematsu, Shigeki Yagyu, Nobuyoshi Nagao, et al.
Page
of 7
Search research articles
Search
Showing results (1-10 of 65) with videos related to
Sort By:
Page
of 7
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology
|
June 4, 2023
[Engineering memory-rich CAR-T cells by a piggyBac transposon system]
Shigeki Yagyu
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology
|
August 4, 2024
[Adoptive cell therapy for solid tumors]
Kenichi Sakamoto, Shigeki Yagyu
International Journal of Clinical Oncology
|
March 1, 2023
piggyBac-transposon-mediated CAR-T cells for the treatment of hematological and solid malignancies
Shigeki Yagyu, Yozo Nakazawa
BMJ Case Reports
|
January 1, 2022
Infantile mediastinal neuroblastoma presenting as an oncologic emergency: usefulness of serum-based <i>MYCN</i> gene amplification analysis for risk stratification
Masaya Suematsu, Shigeki Yagyu, Hajime Hosoi, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
May 30, 2015
An Inducible Caspase-9 Suicide Gene to Improve the Safety of Therapy Using Human Induced Pluripotent Stem Cells
Shigeki Yagyu, Valentina Hoyos, Francesca Del Bufalo, et al.
Molecular Therapy. Methods & Clinical Development
|
September 15, 2016
Multiple mechanisms determine the sensitivity of human-induced pluripotent stem cells to the inducible caspase-9 safety switch
Shigeki Yagyu, Valentina Hoyos, Francesca Del Bufalo, et al.
Biochemical and Biophysical Research Communications
|
October 24, 2022
Non-viral inducible caspase 9 mRNA delivery using lipid nanoparticles against breast cancer: An in vitro study
Ikumi Nakashima, Shoji Saito, Eiichi Akahoshi, et al.
Pediatric Blood & Cancer
|
March 4, 2011
Detection of MYCN DNA in the cerebrospinal fluid for diagnosing isolated central nervous system relapse in neuroblastoma
Tomiko Kimoto, Masami Inoue, Sadao Tokimasa, et al.
Cancer Cell International
|
June 4, 2020
Oncogenic role of HMGA2 in fusion-negative rhabdomyosarcoma cells
Kazutaka Ouchi, Mitsuru Miyachi, Shigeki Yagyu, et al.
Frontiers in Immunology
|
February 14, 2022
<i>PiggyBac</i> Transposon-Mediated CD19 Chimeric Antigen Receptor-T Cells Derived From CD45RA-Positive Peripheral Blood Mononuclear Cells Possess Potent and Sustained Antileukemic Function
Masaya Suematsu, Shigeki Yagyu, Nobuyoshi Nagao, et al.
Page
of 7